DENTSPLY SIRONA Inc.
XRAY | NASDAQ
$9.93
+$0.49 (+5.19%)
Sep 22, 2026, 2:41 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 898M | 880M | 961M | 904M | 936M | 879M | 905M | 951M | 984M | 953M | 1.01B | 947M | 1.03B | 978M | 983M | 947M | 1.02B | 969M | 1.09B | 1.04B | 1.06B | 1.03B |
Cost of Revenue | 405M | 453M | 518M | 463M | 446M | 413M | 459M | 456M | 473M | 447M | 490M | 452M | 478M | 459M | 466M | 439M | 442M | 448M | 495M | 471M | 467M | 447M |
Gross Profit | 493M | 427M | 443M | 441M | 490M | 466M | 446M | 495M | 511M | 506M | 522M | 495M | 550M | 519M | 517M | 508M | 581M | 521M | 593M | 569M | 595M | 579M |
Operating Income | 82M | 30M | 268M | 46M | -128M | 63M | -509M | -462M | 50M | 42M | 73M | -236M | 80M | -2M | 65M | -1.22B | 119M | 97M | 154M | 132M | 154M | 150M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1M | n/a |
Pretax Income | 72M | -42M | -147M | -230M | -153M | 44M | -523M | -478M | 34M | 31M | 57M | -250M | 46M | -28M | 8M | -1.24B | 91M | 87M | 138M | 113M | 131M | 145M |
Net Income | 37M | -10M | -146M | -427M | -45M | 20M | -430M | -494M | -4M | 18M | 67M | -266M | 86M | -19M | -15M | -1.08B | 73M | 69M | 102M | 84M | 96M | 112M |
Selling & General & Admin | 364M | 353M | 383M | 358M | 343M | 360M | 395M | 391M | 401M | 417M | 416M | 373M | 418M | 418M | 402M | 401M | 410M | 376M | 374M | 395M | 393M | 386M |
Research & Development | 45M | 44M | 40M | 37M | 37M | 36M | 42M | 40M | 41M | 42M | 43M | 46M | 49M | 46M | 43M | 41M | 45M | 45M | 59M | 39M | 43M | 40M |
Other Expenses | 2M | n/a | -248M | n/a | 238M | 7M | 518M | 526M | 19M | 5M | -10M | 312M | 3M | 57M | 7M | 1.28B | 7M | 3M | 6M | 3M | 5M | 3M |
Operating Expenses | 411M | 397M | 175M | 395M | 618M | 403M | 955M | 957M | 461M | 464M | 449M | 731M | 470M | 521M | 452M | 1.73B | 462M | 424M | 439M | 437M | 441M | 429M |
Interest Expense | 22M | 24M | 22M | 23M | 21M | 19M | 16M | 18M | 17M | 18M | 23M | 19M | 22M | 20M | 19M | 14M | 15M | 12M | 12M | 14M | 16M | 14M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 816M | 850M | 693M | 858M | 1.06B | 816M | 1.41B | 1.41B | 934M | 911M | 939M | 1.18B | 948M | 980M | 918M | 2.17B | 904M | 872M | 934M | 908M | 908M | 876M |
Income Tax Expense | 36M | -32M | -2M | 198M | -109M | 25M | -95M | 17M | 38M | 14M | -15M | 16M | -39M | -5M | 23M | -164M | 18M | 18M | 36M | 29M | 35M | 33M |
Shares Outstanding (Basic) | 199.7M | 199.9M | 199.6M | 199.5M | 199.3M | 199.1M | 203.2M | 201M | 205.6M | 207.4M | 210M | 211.8M | 211.9M | 214.5M | 215.1M | 214.9M | 214.9M | 217.01M | 218M | 218.6M | 218.4M | 218.8M |
Shares Outstanding (Diluted) | 200.5M | 199.9M | 199.6M | 199.5M | 199.3M | 199.8M | 203.2M | 201M | 205.6M | 208.5M | 210.9M | 211.8M | 213.1M | 214.5M | 215.1M | 214.9M | 215.3M | 217.8M | 219.2M | 220.5M | 220.7M | 219.9M |
EPS (Basic) | 0.18 | -0.05 | -0.73 | -2.14 | -0.23 | 0.10 | -2.16 | -2.46 | -0.02 | 0.09 | 0.32 | -1.26 | 0.41 | -0.11 | -0.07 | -5.01 | 0.34 | 0.32 | 0.47 | 0.39 | 0.44 | 0.51 |
EPS (Diluted) | 0.18 | -0.05 | -0.73 | -2.14 | -0.23 | 0.10 | -2.16 | -2.46 | -0.02 | 0.09 | 0.32 | -1.26 | 0.40 | -0.11 | -0.07 | -5.01 | 0.34 | 0.32 | 0.47 | 0.38 | 0.43 | 0.51 |
EBITDA | 258M | 61M | -32M | -115M | -41M | 150M | -419M | -371M | 137M | 135M | 165M | -143M | 154M | 76M | 106M | -1.15B | 189M | 183M | 235M | 212M | 234M | 247M |
EBIT | 94M | -18M | -125M | -207M | -129M | 71M | -507M | -460M | 51M | 49M | 80M | -231M | 68M | -8M | 27M | -1.23B | 106M | 99M | 150M | 127M | 146M | 159M |
Depreciation & Amortization | 164M | 79M | 93M | 92M | 88M | 79M | 88M | 89M | 86M | 86M | 85M | 88M | 86M | 84M | 79M | 82M | 83M | 84M | 85M | 85M | 88M | 88M |
Add to Watchlist
Select watchlists to add or remove XRAY